Trials / Completed
CompletedNCT02929264
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Abide Therapeutics · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
An fMRI study in healthy volunteers to investigate the effects of ABX-1431 on experimental hyperalgesia and its neural correlates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABX-1431 | Capsules, 40 mg, single dose |
| DRUG | Placebo | Capsules, single dose |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-10-11
- Last updated
- 2018-04-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02929264. Inclusion in this directory is not an endorsement.